Bixiye
QP33-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) Criteria: Strensiq (asfotase alfa)
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2018
Natiijooyinka Raadinta
Soo bandhiga 2331 - 2340 ee natiijooyinka 4296
Bixiye
QP7-18 Disclosure of Ownership Form
Taariikhda uu dhaqangalayo Barnaamijka: Jan 18, 2018
Bixiye
QP9-18 New Drug-Related Pharmacy Step Therapy (ST) Program Ophthalmic Antihistamine
Taariikhda uu dhaqangalayo Barnaamijka: 05, Feb 2018
Bixiye
QP27-17 Viewing Chiropractic Benefits
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 10, 2017
Bixiye
QP41-17 Participation Status in the High Value and Access Networks
Taariikhda uu dhaqangalayo Barnaamijka: Nov 30, 2017
Bixiye
QP29-17 Pharmacy Benefit Exclusion for Kymriah
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 21, 2017
Bixiye
QP18-18 Medical Drug Exclusion Lists Expanded to Include Ixifi, Durolane, Visco 3 and TriVisc
Taariikhda uu dhaqangalayo Barnaamijka: Mar 08, 2018
Bixiye
QP41-18 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP33-17 ICD-10 Grouper Updates
Taariikhda uu dhaqangalayo barnaamijka: Okt 17, 2017
Bixiye
QP10-18 Routes of Administration Pharmacy Benefit Exclusion
Taariikhda uu dhaqangalayo Barnaamijka: 05, Feb 2018